MISTRAS Group Receives Frost & Sullivan’s 2026 Global NDT Field Inspection Services Company of the Year Recognition for Excellence in Integrated Asset Integrity and Digital Execution
MISTRAS Group delivers customer-centric asset integrity solutions that drive operational efficiency and…
Nxera Pharmas QUVIVIQ (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with…
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy – CORRECTION
April 10, 2026 16:09 ET | Source: Mesoblast Limited Working with Parent…
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
April 10, 2026 17:02 ET | Source: Replimune, Inc. WOBURN, Mass., April…
Vonage Receives Frost & Sullivan’s 2025 Asia-Pacific Communications Platform-as-a-Service Company of the Year Recognition
Vonage is recognized for its market leadership in omnichannel communications, trusted brand…
AT&T Receives Frost & Sullivan’s 2026 US Public Safety Solutions Company of the Year Recognition for Excellence in Mission-Critical Connectivity
AT&T is recognized for advancing public safety communications through ubiquitous connectivity, innovation,…
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
April 07, 2026 08:05 ET | Source: NextCure The U.S. Food and…
TP Receives Frost & Sullivan’s 2026 India Company of the Year Recognition for Excellence in Customer Experience Management Services
This recognition highlights TP's leadership in digital transformation, responsible AI adoption, and…
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON”…
Matinas BioPharma Receives Notice of Non-Compliance withNYSE AmericanContinued Listing Standards
BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc.…
